Drug Targeting Organ-Specific Strategies

References 229
[43] Chaouchi NA, Vazquez, Galanaud P, Leprince C, J. Immunol. 1995, 154, 3096–3104.
[44] Vuist W.MJ, Levy R, Maloney DG, Blood 1994, 83, 899–906.
[45] Baselga J, Mendelsohn J, Pharmacol. Ther. 1994, 64, 127–154.
[46] Shepard HM, Lewis GD, Sarup JC, Fendly BM, Maneval D, Mordenti J, Figari I, Kotts CE, Palladino
MA, Ullrich A, Slamon D, J. Clin. Immunol. 1991, 11, 117–127.
[47] Wu X, Fan Z, Masui H, Rosen S, Mendelsohn J, J. Clin. Invest. 1995, 95, 1897–1905.
[48] Schneider-Gadicke E, Riethmuller G, Eur. J. Cancer 1995, 31, 1326–1330.
[49] Greiner JW, Guadagni F, Roselli M, Nieroda CA, Anti-cancer Res. 1996, 16, 2129–2133.
[50] Krebber A, Bornhauser S, Burmester J, Honegger A, Willuda J, Bosshard HR, Plückthun A, J.
Immonol. Methods 1997, 201, 35–55.
[51] Reiter Y, Brinkmann U, Lee B, Pastan I, Nature Biotechnol. 1996, 14, 1239–1245.
[52] Orlandi R, Gussow DH, Jones PT, Winter G, Proc. Natl Acad. Sci. USA 1989, 86, 3833–3837.
[53] Hoogenboom M, Griffiths AD, Johnson KS, Chiswell DJ, Hudson P, Winter G, Nucleic Acids
Res. 1991, 19, 4133–4137.
[54] Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR, Annu. Rev. Immunol. 1994, 12, 433–455.
[55] Huls GA, Heijnen IA, Cuomo ME, Koningsberger JC, Wiegman L, Boel E, Van der Vuurst de
Vries AR, Loyson SA, Helfrich W, Van Berge Henegouwen GP, Van Meijer M, de Kruif J,
Logtenberg T, Nature Biotechnol. 1999, 17, 276–281.
[56] Davis CG, Gallo ML, Corvalon, Cancer Metast. Rev. 1999, 18, 421–425.
[57] Yokota T, Milenic DE, Whitlow M, Schlom J, Cancer Res. 1992, 52, 3402–3408.
[58] Jurcic JG, Scheinberg DA, Houghton AN, In: Cancer Chemotherapy and Biological Response
Modifiers Annual 16 (Eds Pinedo HM, Longo DL, Chabner BA), pp. 168–188. Elsevier Science,
Amsterdam, 1996.
[59] Caron PC, Scheinberg DA, Curr. Opin. Oncol. 1994, 6, 14–22.
[60] Dall’Acqua W, Carter P, Curr. Opin. Struct. Biol. 1998, 8, 443–450.
[61] Jung S, Plückthun A, Protein Eng. 1997, 10, 959–966.
[62] Willuda J, Honegger A, Waibel R, Schubiger PA, Stahel R, Zangemeister- Wittke U, Plückthun
A, Cancer Res. 1999, 59, 5758–5767.
[63] Helfrich W, Haisma HJ, Magdolen V, Luther T, Blom VJJ, Westra J, van der Hoeven R, Kroesen
BJ, Molema G, de Leij L, J. Immunol. Methods 2000, 237, 131–145.
[64] Thrush GR, Lark LR, Clinchy BC, Vitetta ES, Annu. Rev. Immunol. 1996, 14, 49–71.
[65] Dillman RO, Johnson DE, Ogden J, Beidler D, Mol. Biotherapy. 1989, 1, 250–255.
[66] Ghose T, Norvell ST, Guclu A, Cameron D, Bodurtha A, MacDonald AS, Br. Med. J. 1972, 3,
495–499.
[67] Goldenberg DM, Am. J. Med. 1993, 94, 297–312.
[68] Trail PA, Willner D, Hellstrom KE, Drug Deliv. Res. 1995, 34, 196–209.
[69] King HD, Yurgaitis D, Willner D, Firestone RA, Yang MB, Lasch SJ, Hellstrom KE, Trail PA,
Bioconjug. Chem. 1999, 10, 279–288.
[70] Smith AL, Nicolaou KC, J. Med. Chem. 1996, 39, 2103–2117.
[71] Hinman LM, Hamann PR, Wallace R, Menendez AT, Durr FE, Upeslacis J, Cancer Res. 1993, 53,
3336–3342.
[72] Lode HN, Reisfeld RA, Handgretinger R, Nicolaou KC, Gaedicke Gand Wrasidlo W, Cancer
Res. 1998, 58, 2925–2928.
[73] Wilder RB, DeNardo GL, DeNardo SJ, J. Clin. Oncol. 1996, 14, 1383–1400.
[74] Stigbrand T, Ullen A, Sandstrom P, Mirzaie-Joniani H, Sundstrom B, Nilsson B, Arlesting L,
Norrlund RR, Ahlstrom KR, Hietala S, Acta Oncol. 1996, 35, 259–265.
[75] Kroesen BJ, Helfrich W, Molema G and de Leij L, Adv. Drug. Del. Rev. 1998, 31, 105–129.
[76] Staerz UD, Kanagawa O, Bevan MJ, Nature 1985, 314, 628–631.
[77] Pluckthun A, Pack P, Immunotechnology 1997, 3, 83–105.
[78] Schmidt M, Wels W, Br. J. Cancer 1996, 74, 853–862.
[79] Van Spriel AB, Ojik HH, van de Winkel JGJ, Immunol. Today 2000, 21, 391–397.
[80] Kroesen BJ, Helfrich W, Bakker A, Wubbema AS, Bakker H, Kal HB, The TH, de Leij L, Int. J.
Cancer 1995, 61, 812–818.
[81] Huennekens FM, Trend. Biotechnol. 1994, 12, 234–239.
[82] Bagshawe KD, Clin. Pharmacokinet. 1994, 27, 368–376.
[83] Kerr DE, Schreiber GJ, Vrudhula VM, Svensson HP, Hellström I, Hellström KE, Senter PD,
Cancer Res. 1995, 55, 3558–3563.
[84] Haisma HJ, Boven E, van Muijen M, de Jong J, van der Vijgh WJ, Pinedo HM, Br. J. Cancer 1992,
66, 474–478.